Century Therapeutics

IPSCNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$342.232 M

$1.89 +2.16%

Close of 22 Sept 2026

Revenue

$109.2M

#2476 by revenue

Earnings

-$9.58M

Loss-making

Shares outstanding

181,075,321

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#78Fennec PharmaceuticalsFENC$385.7M
#79OcugenOCGN$352.7M
#80Century TherapeuticsIPSC$342.2M
#81X4 PharmaceuticalsXFOR$340.1M
#82Lexeo TherapeuticsLXEO$333.9M

What if Century Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$166,969.02

Per share 88,343× higher

Bitcoin $1.74T

$9,618.40

Per share 5,089× higher

Nvidia $5.52T

$30,461.17

Per share 16,117× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Century Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.